GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RGBP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Regen Biopharma Inc stock price on Wednesday moving 14.04% between high and low
(Updated on Apr 17, 2024)

Sell candidate since Apr 05, 2024 Loss -21.14% PDF

The Regen Biopharma Inc stock price fell by -1.05% on the last day (Wednesday, 17th Apr 2024) from $0.574 to $0.568. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 14.04% from a day low at $0.568 to a day high of $0.648. The price has fallen in 7 of the last 10 days and is down by -28.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 2 thousand shares were bought and sold for approximately $1.13 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.47% during the next 3 months and, with a 90% probability hold a price between $0.269 and $0.580 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RGBP Signals & Forecast

There are few to no technical positive signals at the moment. The Regen Biopharma Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.617 and $0.741. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, January 25, 2024, and so far it has fallen -45.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Regen Biopharma Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0797 between high and low, or 14.04%. For the last week the stock has had daily average volatility of 18.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RGBP) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Regen Biopharma Inc to open at $0.594, and during the day (based on 14 day Average True Range), to move between $0.448 and $0.687, which gives a possible trading interval of +/-$0.120 (+/-21.08%) up or down from last closing price. If Regen Biopharma Inc takes out the full calculated possible swing range there will be an estimated 42.15% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.610, some $0.0422 (7.43%) from the current price of $0.568, our system finds the risk reward not very attractive.

Is Regen Biopharma Inc stock A Buy?

Regen Biopharma Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.783 Strong Sell Candidate Unchanged

Predicted Opening Price for Regen Biopharma Inc of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$0.594 ( 4.68%) $0.568

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RGBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.674 18.72 %
R2 0.644 13.35 %
R1 0.625 10.04 %
Current price: 0.568
Support S1 0.564 -0.683 %
S2 0.545 -4.00 %
S3 0.515 -9.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.690 21.52 %
R2 0.650 14.48 %
R1 0.610 7.43 %
Current price 0.568
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Regen Biopharma Inc Stock and on which exchange is it traded?
The symbol for Regen Biopharma Inc is RGBP and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Regen Biopharma Inc Stock?
Regen Biopharma Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Regen Biopharma Inc Stock?
Regen Biopharma Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regen Biopharma Inc Stock.

What's the current price of Regen Biopharma Inc Stock?
As of the end of day on the 2024-04-17, the price of an Regen Biopharma Inc (RGBP) share was $0.568.

What is the 52-week high and low for Regen Biopharma Inc Stock?
The 52-week high for Regen Biopharma Inc Stock is $2.62 and the 52-week low is $0.401.

What is the market capitalization of Regen Biopharma Inc Stock?
As of the 2024-04-17, the market capitalization of Regen Biopharma Inc is 2.13M.

When is the next earnings date for Regen Biopharma Inc?
The upcoming earnings date for Regen Biopharma Inc is Jul 22, 2024.
Click to get the best stock tips daily for free!

About Regen Biopharma Inc

Regen Biopharma Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La ... RGBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT